3Nakagawara J, Minematsu K, Okada Y, et al. Thrombolysis with 0. 6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: The Japan post-Marketing Alteplase Registration Study (J- MARS) [ J]. Stroke,2010,41 (9) : 1984-1989.
4Zhou XY,Wang SS,Marnie LC,et al. Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke [ J ]. J Clin Neuresci ,2010,17 (8) :988-992.
5Lees KR, Bluhmki E, yon Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J]. The Lancet, 2010 (9727) :1695-1703.
6Ebinger M, Kunz A, Wendt M, et al, Effects of golden hour thrombolysis : a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy [ J ]. JAMA neurology, 2015,72 ( 1 ) :25-30.
7Ebinger M, Lindenlaub S, Kunz A, et al. Prehospital thrombolysis : a manual from Berlin[J]. J Vis Exp, 2013(81 ) :e50534.
